• Hypertrophic Cardiomyopathy (HCM)
  • Eyecare
  • Urothelial Carcinoma
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Asthma
  • Atrial Fibrillation
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

More from Desktop Resources (August 2006)

Article

The top five HMO enrollment states also have high immigrant populations, says Cynthia Marcotte Stamer, a member of Glast, Phillips & Murray, PC, Dallas, Texas. "Among the top 20 HMO enrollment states, California, New York, Texas and Florida also are on the list of states qualifying for special Emergency Medical Treatment and Active Labor Act (EMTALA) Medicare reimbursements for undocumented aliens under MMA Section 1028."

The top five HMO enrollment states also have high immigrant populations, says Cynthia Marcotte Stamer, a member of Glast, Phillips & Murray, PC, Dallas, Texas. "Among the top 20 HMO enrollment states, California, New York, Texas and Florida also are on the list of states qualifying for special Emergency Medical Treatment and Active Labor Act (EMTALA) Medicare reimbursements for undocumented aliens under MMA Section 1028."

According to Joseph M. Mack, MPA, senior vice president Beecher Carlson Healthcare Practice, in Irvine, Calif., "Since the 1970s, many medical groups have marketed directly to immigrants. If not enrolled in managed care plans, immigrants frequently pay for services in cash, which is a much better reimbursement than managed care provides."

"With more cost being shifted to consumers and more expensive technologies coming out every day that can or will stand to make a great difference in the health and longevity of consumers-particularly the fields of molecular and genomic diagnostics and treatments-look for more consumers to realize that HMOs are the best way to cap their out-of-pocket costs," says Ricardo Guggenheim, MD, vice president, clinical development and design, McKesson Health Solutions.

"If this is true, then it suggests that HMOs should continue to market New York for increased HMO enrollment. Conversely, enrollment in HMOs declined at a greater rate than HMO penetration in Pennsylvania. This may be the result of increased enrollment in HSAs-and therefore PPOs-in siphoning membership from HMOs."

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.